跳至主要内容
临床试验/NCT01865357
NCT01865357已完成不适用

Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI:"SCI-COG" Study

University Hospital, Bordeaux1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2012年8月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
117
试验地点
1
主要终点
Correlation between fractional anisotropy (FA) value and cognitive z scores or cognitive impairment indexes for each domains

研究概览

简要总结

Clinically isolated demyelinating syndromes (CIS) can evolve into multiple sclerosis (MS). Cognitive deficiencies could occur at this early stage and concern mainly information processing speed (IPS) and their mechanisms are not fully understood. Diffusion Tensor Imaging (DTI) can help in the understanding of these mechanisms.

详细描述

This is a prospective cohort, observational, longitudinal, monocentric study. This study will include 60 patients with CIS followed for 1 year and 60 healthy subjects.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients:
  • •Men and Women
  • •≥16 years
  • •Fluent French speaker
  • •Clinically isolated neurological syndrome (CIS) compatible with a demyelinating inflammatory episode within the central nervous system, potentially beginning multiple sclerosis (MS) whatever the mode of presentation
  • •Between 60 and 180 days from the onset
  • •At least two clinically silent lesions on their T2-weighted brain or spinal MRI scan with a size of at least 3 mm, at least one of which being cerebral, ovoid, or periventricular
  • •Having a medical insurance
  • •Free and informed consent signed
  • •Controls:
  • •Men and Women
  • •≥18 years
  • •Fluent French speaker
  • •Having a medical insurance
  • •Free and informed consent signed

排除标准

  • •Patients:
  • •Prior documented neurological episode suggestive of MS.
  • •Other ongoing neurological diseases.
  • •Known chronic systemic diseases as judged by the investigator (for instance: lupus, Gougerot-Sjögren, sarcoidosis, sclerodermia, Crohn disease,...).
  • •Other causes (trauma, tumor, radiotherapy, infections, vascular diseases, neuromyelitis optica).
  • •Current dependence on alcohol or drugs.
  • •Dosage change, stop or start of hypnotic or anxiolytic or antidepressive treatment less than 15 days
  • •MRI contra-indications.
  • •Steroid treatment less than one month (be taken orally or by infusion) at the dosage of 500mg daily.
  • •Controls:
  • •Known chronic psychiatric or neurologic diseases which could interfere with neuropsychological testing, not taking into account stable and mild depressive syndrome
  • •Known chronic systemic diseases as judged by the investigator (for instance: lupus, Gougerot-Sjögren, sarcoidosis, scleroderma, Crohn disease...).
  • •MS familial history
  • •Current dependence on alcohol or drugs
  • •Known cognitive impairment
  • •Prior neuropsychological testing with the same tests less than one year
  • •Dosage change, stop or start of hypnotic or anxiolytic or antidepressive treatment less than 2 months
  • •Steroid treatment less than one month (be taken orally or by infusion) at the dosage of 500mg daily.
  • •MRI contra-indications
  • •Steroid treatment less than one month (be taken orally or by infusion) at the dosage of 500mg daily.

研究组 & 干预措施

Control

Experimental

healthy subject

干预措施: Eye movement (Other)

Patient

Experimental

Clinically isolated neurological syndrome (CIS) compatible with a demyelinating inflammatory episode within the central nervous system, potentially beginning multiple sclerosis (MS) whatever the mode of presentation

干预措施: Brain MRI - Clinical and cognitive evaluation (Other)

Patient

Experimental

Clinically isolated neurological syndrome (CIS) compatible with a demyelinating inflammatory episode within the central nervous system, potentially beginning multiple sclerosis (MS) whatever the mode of presentation

干预措施: Eye movement (Other)

Control

Experimental

healthy subject

干预措施: Brain MRI - Clinical and cognitive evaluation (Other)

结局指标

主要结局

Correlation between fractional anisotropy (FA) value and cognitive z scores or cognitive impairment indexes for each domains

时间窗: visit 2 - 1 year after inclusion

IPS, attention, working memory, episodic memory and executive functions), established by voxel-wise statistics (TBSS) in CIS patients

次要结局

  • Comparison of cognitive scores at each test between CIS patients and controls(D0 and V2 - 1 year after the inclusion)
  • Proportion of patients with cognitive impairment (≥ 3 tests impaired) and correlations with anxiety, depressive syndrome and fatigue(D0 and V2 - 1 year after the inclusion)
  • Comparison of skeleton of FA between CIS patients and healthy subjects(V2 - 1 year after the inclusion)
  • Comparison of statistical maps of FA(D0 and V2 - 1 year after the inclusion)
  • Correlations between cognitive scores and mean cortical thickness and deep grey nuclei volumes in CIS patients(D0 and V2 - 1 year after the inclusion)
  • Comparison of cognitive scores at each test and eye movements scores(D0 and V2 - 1 year after the inclusion)

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验